 | • レポートコード：MRC2-11QY05044 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は内臓痛のグローバル市場について調査・分析したレポートです。種類別（鎮痛剤、疼痛修飾剤）市場規模、用途別（間質性膀胱炎、クローン病、過敏性腸症候群、慢性前立腺炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別内臓痛の競争状況、市場シェア ・世界の内臓痛市場：種類別市場規模 2015年-2020年（鎮痛剤、疼痛修飾剤） ・世界の内臓痛市場：種類別市場規模予測 2021年-2026年（鎮痛剤、疼痛修飾剤） ・世界の内臓痛市場：用途別市場規模 2015年-2020年（間質性膀胱炎、クローン病、過敏性腸症候群、慢性前立腺炎） ・世界の内臓痛市場：用途別市場規模予測 2021年-2026年（間質性膀胱炎、クローン病、過敏性腸症候群、慢性前立腺炎） ・北米の内臓痛市場分析：米国、カナダ ・ヨーロッパの内臓痛市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの内臓痛市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の内臓痛市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの内臓痛市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Johnson & Johnson、Abbvie、Takeda、Allergan、AstraZeneca ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutting or burning. Visceral pain is diffuse, difficult to localize and often referred to a distant, usually superficial, structure. It may be accompanied by symptoms such as nausea, vomiting, changes in vital signs as well as emotional manifestations. The pain may be described as sickening, deep, squeezing, and dull. Distinct structural lesions or biochemical abnormalities explain this type of pain in only a proportion of patients. These diseases are grouped under gastrointestinal neuromuscular diseases (GINMD). Others can experience visceral pains, often very intense in nature, without any evidence of structural, biochemical or histolopathologic reason for such symptoms. These diseases are grouped under functional gastrointestinal disorders (FGID) and the pathophysiology and treatment can vary greatly from GINMD. The two major single entities among functional disorders of the gut are functional dyspepsia and irritable bowel syndrome.
Growing focus on research and development by pharmaceutical companies and government initiatives are expected to boost the visceral pain industry over the forecast period. The market is projected to witness significant gain during the forecast period owing to increasing collaboration within pharmaceutical companies. Moreover, growth in the interest of scientists and researchers in studying the pain originating from internal organs has mirrored in the consciousness of the importance of visceral pain in patients. Asia Pacific is expected to grow at the highest CAGR of 6.2% from 2017 to 2024. North America has been leading the market for visceral pain, it is expected that African countries will witness exponential growth during the forecast period.
Market Analysis and Insights: Global Visceral Pain Market
The global Visceral Pain market size is projected to reach US$ 1020 million by 2026, from US$ 979.4 million in 2020, at a CAGR of 3.7%% during 2021-2026.
Global Visceral Pain Scope and Market Size
Visceral Pain market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Visceral Pain market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Johnson & Johnson
Abbvie
Takeda
Allergan
AstraZeneca
…
Market segment by Type, the product can be split into
Analgesics
Pain Modifiers
Market segment by Application, split into
Interstitial Cystitis
Crohn’s
Irritable Bowel
Chronic Prostatitis
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Visceral Pain Revenue
1.4 Market by Type
1.4.1 Global Visceral Pain Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Analgesics
1.4.3 Pain Modifiers
1.5 Market by Application
1.5.1 Global Visceral Pain Market Share by Application: 2020 VS 2026
1.5.2 Interstitial Cystitis
1.5.3 Crohn’s
1.5.4 Irritable Bowel
1.5.5 Chronic Prostatitis
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Visceral Pain Market Perspective (2015-2026)
2.2 Global Visceral Pain Growth Trends by Regions
2.2.1 Visceral Pain Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Visceral Pain Historic Market Share by Regions (2015-2020)
2.2.3 Visceral Pain Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Visceral Pain Market Growth Strategy
2.3.6 Primary Interviews with Key Visceral Pain Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Visceral Pain Players by Market Size
3.1.1 Global Top Visceral Pain Players by Revenue (2015-2020)
3.1.2 Global Visceral Pain Revenue Market Share by Players (2015-2020)
3.1.3 Global Visceral Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Visceral Pain Market Concentration Ratio
3.2.1 Global Visceral Pain Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Visceral Pain Revenue in 2019
3.3 Visceral Pain Key Players Head office and Area Served
3.4 Key Players Visceral Pain Product Solution and Service
3.5 Date of Enter into Visceral Pain Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Visceral Pain Historic Market Size by Type (2015-2020)
4.2 Global Visceral Pain Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Visceral Pain Market Size by Application (2015-2020)
5.2 Global Visceral Pain Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Visceral Pain Market Size (2015-2020)
6.2 Visceral Pain Key Players in North America (2019-2020)
6.3 North America Visceral Pain Market Size by Type (2015-2020)
6.4 North America Visceral Pain Market Size by Application (2015-2020)
7 Europe
7.1 Europe Visceral Pain Market Size (2015-2020)
7.2 Visceral Pain Key Players in Europe (2019-2020)
7.3 Europe Visceral Pain Market Size by Type (2015-2020)
7.4 Europe Visceral Pain Market Size by Application (2015-2020)
8 China
8.1 China Visceral Pain Market Size (2015-2020)
8.2 Visceral Pain Key Players in China (2019-2020)
8.3 China Visceral Pain Market Size by Type (2015-2020)
8.4 China Visceral Pain Market Size by Application (2015-2020)
9 Japan
9.1 Japan Visceral Pain Market Size (2015-2020)
9.2 Visceral Pain Key Players in Japan (2019-2020)
9.3 Japan Visceral Pain Market Size by Type (2015-2020)
9.4 Japan Visceral Pain Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Visceral Pain Market Size (2015-2020)
10.2 Visceral Pain Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Visceral Pain Market Size by Type (2015-2020)
10.4 Southeast Asia Visceral Pain Market Size by Application (2015-2020)
11 India
11.1 India Visceral Pain Market Size (2015-2020)
11.2 Visceral Pain Key Players in India (2019-2020)
11.3 India Visceral Pain Market Size by Type (2015-2020)
11.4 India Visceral Pain Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Visceral Pain Market Size (2015-2020)
12.2 Visceral Pain Key Players in Central & South America (2019-2020)
12.3 Central & South America Visceral Pain Market Size by Type (2015-2020)
12.4 Central & South America Visceral Pain Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Visceral Pain Introduction
13.1.4 Pfizer Revenue in Visceral Pain Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Visceral Pain Introduction
13.2.4 Johnson & Johnson Revenue in Visceral Pain Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Abbvie
13.3.1 Abbvie Company Details
13.3.2 Abbvie Business Overview
13.3.3 Abbvie Visceral Pain Introduction
13.3.4 Abbvie Revenue in Visceral Pain Business (2015-2020)
13.3.5 Abbvie Recent Development
13.4 Takeda
13.4.1 Takeda Company Details
13.4.2 Takeda Business Overview
13.4.3 Takeda Visceral Pain Introduction
13.4.4 Takeda Revenue in Visceral Pain Business (2015-2020)
13.4.5 Takeda Recent Development
13.5 Allergan
13.5.1 Allergan Company Details
13.5.2 Allergan Business Overview
13.5.3 Allergan Visceral Pain Introduction
13.5.4 Allergan Revenue in Visceral Pain Business (2015-2020)
13.5.5 Allergan Recent Development
13.6 AstraZeneca
13.6.1 AstraZeneca Company Details
13.6.2 AstraZeneca Business Overview
13.6.3 AstraZeneca Visceral Pain Introduction
13.6.4 AstraZeneca Revenue in Visceral Pain Business (2015-2020)
13.6.5 AstraZeneca Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Visceral Pain Key Market Segments
Table 2. Key Players Covered: Ranking by Visceral Pain Revenue
Table 3. Ranking of Global Top Visceral Pain Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Visceral Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Analgesics
Table 6. Key Players of Pain Modifiers
Table 7. Global Visceral Pain Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Visceral Pain Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Visceral Pain Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Visceral Pain Market Share by Regions (2015-2020)
Table 11. Global Visceral Pain Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Visceral Pain Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Visceral Pain Market Growth Strategy
Table 17. Main Points Interviewed from Key Visceral Pain Players
Table 18. Global Visceral Pain Revenue by Players (2015-2020) (Million US$)
Table 19. Global Visceral Pain Market Share by Players (2015-2020)
Table 20. Global Top Visceral Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Visceral Pain as of 2019)
Table 21. Global Visceral Pain by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Visceral Pain Product Solution and Service
Table 24. Date of Enter into Visceral Pain Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Visceral Pain Market Size by Type (2015-2020) (Million US$)
Table 27. Global Visceral Pain Market Size Share by Type (2015-2020)
Table 28. Global Visceral Pain Revenue Market Share by Type (2021-2026)
Table 29. Global Visceral Pain Market Size Share by Application (2015-2020)
Table 30. Global Visceral Pain Market Size by Application (2015-2020) (Million US$)
Table 31. Global Visceral Pain Market Size Share by Application (2021-2026)
Table 32. North America Key Players Visceral Pain Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Visceral Pain Market Share (2019-2020)
Table 34. North America Visceral Pain Market Size by Type (2015-2020) (Million US$)
Table 35. North America Visceral Pain Market Share by Type (2015-2020)
Table 36. North America Visceral Pain Market Size by Application (2015-2020) (Million US$)
Table 37. North America Visceral Pain Market Share by Application (2015-2020)
Table 38. Europe Key Players Visceral Pain Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Visceral Pain Market Share (2019-2020)
Table 40. Europe Visceral Pain Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Visceral Pain Market Share by Type (2015-2020)
Table 42. Europe Visceral Pain Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Visceral Pain Market Share by Application (2015-2020)
Table 44. China Key Players Visceral Pain Revenue (2019-2020) (Million US$)
Table 45. China Key Players Visceral Pain Market Share (2019-2020)
Table 46. China Visceral Pain Market Size by Type (2015-2020) (Million US$)
Table 47. China Visceral Pain Market Share by Type (2015-2020)
Table 48. China Visceral Pain Market Size by Application (2015-2020) (Million US$)
Table 49. China Visceral Pain Market Share by Application (2015-2020)
Table 50. Japan Key Players Visceral Pain Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Visceral Pain Market Share (2019-2020)
Table 52. Japan Visceral Pain Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Visceral Pain Market Share by Type (2015-2020)
Table 54. Japan Visceral Pain Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Visceral Pain Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Visceral Pain Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Visceral Pain Market Share (2019-2020)
Table 58. Southeast Asia Visceral Pain Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Visceral Pain Market Share by Type (2015-2020)
Table 60. Southeast Asia Visceral Pain Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Visceral Pain Market Share by Application (2015-2020)
Table 62. India Key Players Visceral Pain Revenue (2019-2020) (Million US$)
Table 63. India Key Players Visceral Pain Market Share (2019-2020)
Table 64. India Visceral Pain Market Size by Type (2015-2020) (Million US$)
Table 65. India Visceral Pain Market Share by Type (2015-2020)
Table 66. India Visceral Pain Market Size by Application (2015-2020) (Million US$)
Table 67. India Visceral Pain Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Visceral Pain Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Visceral Pain Market Share (2019-2020)
Table 70. Central & South America Visceral Pain Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Visceral Pain Market Share by Type (2015-2020)
Table 72. Central & South America Visceral Pain Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Visceral Pain Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Visceral Pain Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Product
Table 82. Johnson & Johnson Revenue in Visceral Pain Business (2015-2020) (Million US$)
Table 83. Johnson & Johnson Recent Development
Table 84. Abbvie Company Details
Table 85. Abbvie Business Overview
Table 86. Abbvie Product
Table 87. Abbvie Revenue in Visceral Pain Business (2015-2020) (Million US$)
Table 88. Abbvie Recent Development
Table 89. Takeda Company Details
Table 90. Takeda Business Overview
Table 91. Takeda Product
Table 92. Takeda Revenue in Visceral Pain Business (2015-2020) (Million US$)
Table 93. Takeda Recent Development
Table 94. Allergan Company Details
Table 95. Allergan Business Overview
Table 96. Allergan Product
Table 97. Allergan Revenue in Visceral Pain Business (2015-2020) (Million US$)
Table 98. Allergan Recent Development
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Product
Table 102. AstraZeneca Revenue in Visceral Pain Business (2015-2020) (Million US$)
Table 103. AstraZeneca Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Visceral Pain Market Share by Type: 2020 VS 2026
Figure 2. Analgesics Features
Figure 3. Pain Modifiers Features
Figure 4. Global Visceral Pain Market Share by Application: 2020 VS 2026
Figure 5. Interstitial Cystitis Case Studies
Figure 6. Crohn’s Case Studies
Figure 7. Irritable Bowel Case Studies
Figure 8. Chronic Prostatitis Case Studies
Figure 9. Visceral Pain Report Years Considered
Figure 10. Global Visceral Pain Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Visceral Pain Market Share by Regions: 2020 VS 2026
Figure 12. Global Visceral Pain Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Visceral Pain Market Share by Players in 2019
Figure 15. Global Top Visceral Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Visceral Pain as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Visceral Pain Revenue in 2019
Figure 17. North America Visceral Pain Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Visceral Pain Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Visceral Pain Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Visceral Pain Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Visceral Pain Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Visceral Pain Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Visceral Pain Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
慢性腰痛治療の世界市場（～2026年） Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic. Market Analysis and Insights: Global Chronic Low Back Pain Treatment Market The global Chron…- 術後疼痛管理の世界市場（～2026年） Postoperative pain management aims to minimise patient discomfort, facilitate early mobilization and functional recovery, and prevent acute pain developing into chronic pain. Mental health can affect a patient’s recovery and psychological vulnerability is predictive of severe postoperative pain. Edu…
- 鎮痛剤デリバリーの世界市場（～2026年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
- 疼痛管理治療薬の世界市場（～2026年） Market Analysis and Insights: Global Pain Management Therapeutics Market The global Pain Management Therapeutics market size is projected to reach US$ 59160 million by 2026, from US$ 57740 million in 2020, at a CAGR of 2.3%% during 2021-2026. Global Pain Management Therapeutics Scope and Market Size…
- 疼痛管理の世界市場（～2026年） Pain Management could help people release pain or make them feel less painful. These drug function on phsical or mental. Market Analysis and Insights: Global Pain Management Market The global Pain Management market size is projected to reach US$ 3381 million by 2026, from US$ 3213.5 million in 2020,…